Clinical Trial Update: Pharmacogenomics of Interferon and Ribavirin Treatment in Patients With Chronic Hepatitis C Virus Infection

View source ↗

Summary

An update on a clinical trial examining how pharmacogenomics influences interferon and ribavirin treatment for chronic hepatitis C virus infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Interferon (interferon)
• Ribavirin (ribavirin)

Snippet

Sponsor: Bayside Health | Conditions: Hepatitis C | Status: UNKNOWN